Your browser doesn't support javascript.
loading
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - YES.
Chataway, Jeremy.
Affiliation
  • Chataway J; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London, London, UK.
Mult Scler ; 23(4): 505-506, 2017 04.
Article in En | MEDLINE | ID: mdl-27729554
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Outcome Assessment, Health Care / Multiple Sclerosis, Chronic Progressive Limits: Humans Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2017 Document type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Outcome Assessment, Health Care / Multiple Sclerosis, Chronic Progressive Limits: Humans Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2017 Document type: Article Affiliation country: United kingdom